Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.
Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Granules shares
The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.
Bombay High Court Summons Mumbai North-East Candidates Over Election Petition Contesting Shiv Sena UBT Leader Sanjay Patil’s Victory
Chhattisgarh: Accused In BJP Leader Shivprakash Murder Case, Dies In Police Custody
Maharashtra Elections 2024: Minister Girish Mahajan Hints At Announcement Of Poll Dates, Says MCC To Come Into Effect In 15-20 Days
Mumbai: BMC To Set Up Underground Hawker Plaza In Andheri; MLA Ameet Satam Writes To Bhushan Gagrani Demanding Relocation & Feedback
